This statistic displays annual revenue figures of the generics pharmaceutical manufacturing industry in the United States from 2008 to 2013. In 2008, the revenue of generics pharmaceutical manufacturing in the U.S. ranged at around 30 billion U.S. dollars.
Revenue of generic pharmaceutical manufacturing (NAICS 32541b) in the United States from 2008 to 2013 (in billion U.S. dollars)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Metabolic & digestive pharmaceuticals revenue in Argentina 2017-2022
- Basic Statistic Market share of generic pharmaceuticals in Norway 2013-2021
- Premium Statistic Argentina: nervous system pharmaceuticals revenue 2017-2019
- Premium Statistic Growing unbranded generic corporations by absolute Rx growth U.S. 2017-2018
- Basic Statistic Top global generic pharmaceutical companies 2015, by revenue
- Premium Statistic Genitourinary system & sexual hormones market revenue in Argentina 2017-2022
- Premium Statistic Teva Pharmaceutical Industries' generic revenues by region 2016-2023
- Premium Statistic Teva Pharmaceutical Industries' specialty medicines revenues breakdown 2018-2023
- Premium Statistic Pharmaceutical industry revenue in Argentina 2021, by target
- Basic Statistic Public expenditure on blue prescriptions in Norway 2012-2021
About the region
10
- Basic Statistic Alprazolam out of pocket cost in the U.S. 2004-2021
- Premium Statistic Number of rosuvastatin prescriptions in the U.S. 2004-2021
- Basic Statistic Number of fluticasone prescriptions in the U.S. 2004-2021
- Premium Statistic Esomeprazole out of pocket cost U.S. 2006-2021
- Basic Statistic Rosuvastatin out-of-pocket cost U.S. 2004-2021
- Premium Statistic Fluticasone out of pocket cost in the U.S. 2004-2021
- Basic Statistic Esomeprazole prescriptions number U.S. 2007-2021
- Premium Statistic Insulin human out of pocket price in the U.S. 2004-2020
- Basic Statistic Metformin out of pocket price U.S. 2004-2021
- Premium Statistic Number of atenolol prescriptions in the U.S. 2004-2021
Selected statistics
10
- Premium Statistic Sales of Johnson & Johnson 2006-2023 by region
- Basic Statistic Merck & Co cash dividends declared 2006-2023
- Basic Statistic Sanofi's total assets 2007-2023
- Premium Statistic Merck & Co - expenditure on research and development 2006-2023
- Basic Statistic Merck & Co total assets 2009-2023
- Premium Statistic Pfizer's revenues in the U.S. and abroad 2009-2023
- Premium Statistic AstraZeneca's expenditure on research and development 2006-2023
- Premium Statistic Johnson & Johnson's number of employees 2004-2023
- Premium Statistic Sales of Johnson & Johnson worldwide 2011-2023, by segment
- Premium Statistic Global pharmaceutical pipeline by therapy area 2013-2017
Other regions
10
- Basic Statistic Market share of generics in European countries 2021
- Premium Statistic Canadian prices for top generic molecules 2018
- Basic Statistic Worldwide Rx drug sales excluding generics and orphan drugs 2012-2026
- Premium Statistic Forecasted generic drug sales in Mexico 2015-2025
- Premium Statistic Argentina: systemic anti-infective pharmaceuticals revenue 2017-2019
- Premium Statistic Share of generic drugs in the pharmaceutical market in France 2018
- Basic Statistic Sales value of generic pharmaceuticals in Sweden 2013-2022
- Basic Statistic Value share of generic pharmaceuticals market in Czechia 2011-2021
- Basic Statistic Value share of generic pharmaceuticals market in Turkey 2010-2021
- Premium Statistic Biosimilars approved for marketing Europe vs U.S. 2022 by year since approval
Related statistics
10
- Premium Statistic Revenue of ready-mix concrete manufacturing in the U.S., 2009-2021
- Premium Statistic Revenue of dairy wholesaling in the U.S., 2008-2020
- Premium Statistic Revenue of oil drilling & gas extraction in the U.S., 2009-2014
- Premium Statistic Revenue of civic, social & youth organizations in the U.S., 2009-2014
- Premium Statistic Revenue of laundromats in the U.S., 2009-2014
- Premium Statistic Revenue of for-profit universities in the U.S., 2009-2014
- Premium Statistic Revenue of electric power transmission in the U.S., 2009-2014
- Premium Statistic Revenue of mineral & phosphate mining in the U.S., 2009-2014
- Premium Statistic Revenue of loan brokers in the U.S., 2009-2014
- Premium Statistic Revenue of real estate asset management & consulting in the U.S., 2009-2014
Further related statistics
10
- Pfizer's ad spending 2006-2023
- Annual revenue of Sinopharm 2010-2022
- Revenue of Sinopharm 2011-2022, by category
- Number of employees at Sinopharm 2011-2022
- Ping An Insurance's annual revenue 2012-2022
- Net revenue from investment banking at Goldman Sachs 2009-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- CVS Health's total assets 2005-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
Further Content: You might find this interesting as well
Statistics
- Pfizer's ad spending 2006-2023
- Annual revenue of Sinopharm 2010-2022
- Revenue of Sinopharm 2011-2022, by category
- Number of employees at Sinopharm 2011-2022
- Ping An Insurance's annual revenue 2012-2022
- Net revenue from investment banking at Goldman Sachs 2009-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- CVS Health's total assets 2005-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
Statista. (December 31, 2013). Revenue of generic pharmaceutical manufacturing (NAICS 32541b) in the United States from 2008 to 2013 (in billion U.S. dollars) [Graph]. In Statista. Retrieved May 13, 2024, from https://www.statista.com/statistics/291205/revenue-of-generic-pharmaceutical-manufacturing-in-the-us/
Statista. "Revenue of generic pharmaceutical manufacturing (NAICS 32541b) in the United States from 2008 to 2013 (in billion U.S. dollars)." Chart. December 31, 2013. Statista. Accessed May 13, 2024. https://www.statista.com/statistics/291205/revenue-of-generic-pharmaceutical-manufacturing-in-the-us/
Statista. (2013). Revenue of generic pharmaceutical manufacturing (NAICS 32541b) in the United States from 2008 to 2013 (in billion U.S. dollars). Statista. Statista Inc.. Accessed: May 13, 2024. https://www.statista.com/statistics/291205/revenue-of-generic-pharmaceutical-manufacturing-in-the-us/
Statista. "Revenue of Generic Pharmaceutical Manufacturing (Naics 32541b) in The United States from 2008 to 2013 (in Billion U.S. Dollars)." Statista, Statista Inc., 31 Dec 2013, https://www.statista.com/statistics/291205/revenue-of-generic-pharmaceutical-manufacturing-in-the-us/
Statista, Revenue of generic pharmaceutical manufacturing (NAICS 32541b) in the United States from 2008 to 2013 (in billion U.S. dollars) Statista, https://www.statista.com/statistics/291205/revenue-of-generic-pharmaceutical-manufacturing-in-the-us/ (last visited May 13, 2024)
Revenue of generic pharmaceutical manufacturing (NAICS 32541b) in the United States from 2008 to 2013 (in billion U.S. dollars) [Graph], Statista, December 31, 2013. [Online]. Available: https://www.statista.com/statistics/291205/revenue-of-generic-pharmaceutical-manufacturing-in-the-us/